Global Drug UpdatesLATEST PHARMACEUTICAL INTELLIGENCE

Global Drug Information Service

We continuously track new drug approvals and medical literature worldwide, delivering personalised pharmaceutical intelligence to help clients access cutting-edge treatment options.

Scope of Services

• Global New Drug Tracking — monitoring the latest approvals from the Hong Kong Department of Health, US FDA, European EMA and China NMPA;
• Oncology & Rare Disease Frontiers — focusing on immunotherapies, targeted therapies, cell therapies and orphan drugs;
• Clinical Trial Information — curating ongoing clinical trials and recruitment updates in Hong Kong and overseas, with feasibility assessment support;
• Cross-border Medication Guidance — explaining the GBA "Hong Kong-Macao Medicine and Equipment Connect" scheme and pathways for accessing new drugs at designated GBA institutions;
• Personalised Drug Reports — condition-specific drug intelligence summaries for discussion with treating physicians;
• Professional Interpretation — medical team support in interpreting drug information, with referral to specialists for in-depth evaluation when needed.

Sources

All information is drawn from official regulatory announcements, peer-reviewed medical literature and authoritative medical databases to ensure accuracy, objectivity and traceability.

Compliance Statement

The drug information provided by this service is for reference only and does not constitute medical advice or medication guidance. Any medication decision must be made in consultation with your treating physician or licensed pharmacist and in compliance with local regulations.